Berkshire’s $9.7 Billion OxyChem Deal Means What?
Buffett’s firm has spent years amassing a giant stake in Occidental Petroleum (NYSE: OXY), starting with a $10 billion preferred stock and warrant package in 2019 that helped Occidental fund its acquisition of Anadarko.
By mid-2025, Berkshire had built that into a 32.7% equity position, making OXY one of its six largest holdings.
» Read more about: Berkshire’s $9.7 Billion OxyChem Deal Means What? »
Read More
Why Novo May Be the Real Winner in Obesity Drug Boom
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »
Read More
1 Stock to Own for the Next Decade
Every once in a while, a company comes along that feels like the rare exception, a business so well-positioned, diversified, and forward-looking that it could anchor a portfolio for years.
Broadcom is one of those companies and it might be the single best position to hold for the foreseeable future.
Key Points
-
Broadcom combines cyclical chip sales with high-margin recurring software revenue from acquisitions like CA,
» Read more about: 1 Stock to Own for the Next Decade »
Read More
Is This Dental Stock a Stunning Bargain?
Dentsply Sirona (NASDAQ: XRAY), one of the world’s largest makers of dental equipment and supplies, was created in 2016 when Dentsply merged with Sirona Dental Systems.
Fast forward to today, and the company is battling falling sales, mounting losses, and a stock price that has been hammered by more than 44% in the past year.
» Read more about: Is This Dental Stock a Stunning Bargain? »
Read More
1 Stock to Own for the Next Decade
Every once in a while, a company comes along that feels like the rare exception, a business so well-positioned, diversified, and forward-looking that it could anchor a portfolio for years.
Broadcom is one of those companies and it might be the single best position to hold for the foreseeable future.
Key Points
-
Broadcom combines cyclical chip sales with high-margin recurring software revenue from acquisitions like CA,
» Read more about: 1 Stock to Own for the Next Decade »
Read MoreThe Burst
IBM’s Smart Move To Prove It’s an AI Powerhouse
For years, IBM has worn the “missed opportunity” label in artificial intelligence. The company that built Deep Blue, the chess-playing computer, and Watson, the supercomputer, seemed perfectly positioned to dominate AI before anyone else saw it coming.
And yet, while those early breakthroughs made headlines, IBM failed to cash in.
» Read more about: IBM’s Smart Move To Prove It’s an AI Powerhouse »
Read MoreThe Ivy
Billionaire Doubles Down on This AI Powerhouse
Lately, billionaire Philippe Laffont has been making bold moves. During the second quarter, Laffont sold part of his Amazon stake, trimming it by about 5% and turned his attention to a name most retail investors barely know, CoreWeave, a company that sits at the center of the AI infrastructure explosion.
Key Points
-
Laffont slightly reduced Amazon after strong gains,
» Read more about: Billionaire Doubles Down on This AI Powerhouse »
Read MoreThe Daily
Can Nvidia's Stock Still Be a 10-Bagger Investment in the Future?
-
Nvidia’s dominance in the artificial intelligence (AI) chip market has resulted in huge gains for investors.
-
Analysts still see plenty of growth potential in the industry.
-
The stock’s high valuation, however, could limit its upside.
In 10 years,
» Read more about: Can Nvidia's Stock Still Be a 10-Bagger Investment in the Future? »